What the markers are actually measuring
Zonulin is the protein that regulates tight-junction permeability. When zonulin is released — triggered most reliably by gliadin from gluten and by lipopolysaccharide from gram-negative bacterial overgrowth — it disassembles the intercellular junctional proteins that control what crosses the epithelial layer. Practitioner consensus frames zonulin as the upstream signal: it tells you the gate is open. Elevated serum zonulin means proteins, bacterial fragments, and undigested food particles are leaking into systemic circulation, generating the antibody load that drives the downstream inflammation. Zonulin is a leading indicator — it moves first when you remove the trigger, and it moves first when you reintroduce one.
Lipopolysaccharide (LPS) is the endotoxin fragment shed by gram-negative bacteria. Serum LPS — and the antibody titers your body builds against it — is the direct evidence that bacterial debris is crossing the barrier. The mechanism worth understanding: LPS in circulation triggers a transient systemic inflammatory response, and the practitioner corpus documents that even a single endotoxin challenge in lean men produced inflammation followed by a measurable decline in serum testosterone, with no change in LH or FSH. That's the leaky-gut-to-hormone-axis bridge in one experiment. LPS antibodies are a lagging indicator — they reflect cumulative exposure over weeks to months, so they fall slowly even after the barrier seals.
Fecal calprotectin is released by neutrophils when they infiltrate the gut wall. It is the cleanest marker of active intestinal inflammation — not permeability, not immune reactivity, but live inflammatory cells in the mucosa right now. Calprotectin is the marker that distinguishes "irritated gut" from "inflamed gut," and it's the one that moves when you successfully calm the wall itself. Pair it with eosinophil protein X (EPX) — released as a marker of cell-mediated immune response, elevated specifically when the inflammation is allergic or parasitic in origin.
Secretory IgA (sIgA) is the antibody class produced in the mucosal lining itself — the first line of defense at the gut wall. Practitioner framing here is critical: sIgA is bidirectional. High sIgA means the immune system is mounting an active response (often to a pathogen, food antigen, or dysbiotic overgrowth). Low sIgA means the mucosal immune system is exhausted or depressed — which is what happens after prolonged chronic gut stress. You want sIgA in the normal range. Both ends are dysfunction.
The lab table — what to pull, when, and why
| Marker | Sample | Timing | Tier | What it tells you |
|---|---|---|---|---|
| Serum zonulin | Blood | Baseline, Week 4, Week 10 | 🟢 Expert | Tight junction status — leading indicator |
| Anti-LPS IgG/IgM/IgA | Blood | Baseline, Week 10 | 🟢 Expert | Cumulative endotoxin exposure — lagging |
| Fecal calprotectin | Stool | Baseline, Week 4, Week 10 | 🔵 Clinical | Active mucosal inflammation |
| Eosinophil Protein X | Stool | Baseline, Week 10 | 🟢 Expert | Allergic/parasitic inflammation pathway |
| Secretory IgA | Stool | Baseline, Week 10 | 🟢 Expert | Mucosal immune competence (bidirectional) |
| Beta-glucuronidase | Stool | Baseline | 🟢 Expert | Detox/estrogen recirculation in gut |
| Pancreatic elastase-1 | Stool | Baseline | 🔵 Clinical | Pancreatic enzyme sufficiency |
| Lactulose/mannitol urine | Urine | Baseline, Week 10 | 🔵 Clinical | Functional permeability — gold standard |
| Lactulose breath test | Breath | Baseline if SIBO suspected | 🔵 Clinical | Small intestinal bacterial overgrowth |
| Anti-gliadin / food antibody panel | Blood | Baseline | 🟢 Expert | Which proteins are crossing the barrier |
The substrate-cited comprehensive stool panel — the 3-day Genova Diagnostic profile at roughly $495 — captures blood in stool, calprotectin, eosinophil protein, secretory IgA, pancreatic markers, beta-glucuronidase, undigested fats and fibers, microbial diversity, parasites, yeast, and fungal overgrowth in a single pull. Practitioner consensus treats this as the annual baseline panel for anyone running a gut repair protocol, with a repeat at Week 10 to verify resolution. The GI-MAP is the PCR-based alternative — faster turnaround, better for pathogen detection, weaker on functional digestion markers.
The lactulose/mannitol urine challenge remains the functional gold standard for permeability — you drink the two sugars, you collect urine for six hours, and the ratio of large molecule (lactulose, shouldn't cross) to small molecule (mannitol, should cross) tells you whether the barrier is selectively intact. It's the test that survives the academic literature because it measures actual transit, not a surrogate.
The sequencing problem — leading vs lagging
This is where most people misread their own labs. The order of resolution under a successful BPC-157 + glutamine + zinc carnosine protocol typically runs:
- Week 2-4: Symptoms shift first — less bloating, more regular stool, less brain fog. No labs have moved yet.
- Week 4: Calprotectin starts dropping. Zonulin may start dropping if the trigger is removed.
- Week 6-8: Zonulin normalizes. Lactulose/mannitol ratio improves. Calprotectin approaches normal range.
- Week 10: Secretory IgA rebalances. Pancreatic elastase often improves.
- Week 12-16: Anti-LPS antibodies finally decline. Food antibody panels start dropping.
- Month 6+: Full antibody class-switch resolution. Microbial diversity rebuilds.
If you pull anti-LPS antibodies at Week 6 and they haven't moved, that is not a failed protocol. That is the lagging indicator behaving like a lagging indicator.
What's NOT happening yet
- Anti-LPS antibodies don't normalize in a 10-week window. Plan for 4-6 months of declining titers after the barrier seals. The antibody pool is what you've already made; you can only stop adding to it.
- Food antibody panels don't tell you what's currently causing damage. They tell you what crossed the barrier in the last 3-6 months. Useful for identifying historical triggers, not for week-by-week protocol decisions.
- A normal calprotectin doesn't mean the barrier is sealed. It means active inflammation has resolved. Permeability can persist for weeks after inflammation calms — pull zonulin or lactulose/mannitol to confirm.
- Microbial diversity won't show major shifts in 10 weeks unless you're aggressively reseeding. Diversity is the slowest marker to move and the one that requires the longest commitment.
- Stool color and consistency are not labs. They're useful daily compliance signals, but the practitioner corpus is clear: visible undigested fat, fiber, or stool discoloration warrants a panel, not a verdict.
Pull the panel at baseline, pull it again at Week 10, and read the markers in the order they're designed to move — not the order you're impatient to see them in.